Recurrence of Guillain-Barré Syndrome in a pediatric patient
DOI:
https://doi.org/10.33448/rsd-v14i12.50436Keywords:
Guillain - Barré syndrome, Pediatric, Recurrence, Neurology.Abstract
Guillain-Barré Syndrome (GBS) is an acute inflammatory demyelinating polyradiculoneuropathy characterized by progressive, ascending, and symmetrical flaccid paralysis. It is generally considered a benign condition, as only a small proportion of cases progress to death, most commonly due to acute respiratory failure. GBS is an autoimmune disorder typically preceded by a respiratory or gastrointestinal infection within the previous six weeks, triggering immune-mediated damage to the myelin sheath by activated macrophages. The aim of the present study was to report the case of a child presenting with two clinically compatible episodes suggestive of recurrent Guillain–Barré syndrome. Neurological examination revealed ataxia, with muscle strength graded 2/5 in the lower limbs and 4/5 in the upper limbs. The patient had a prior history of hospitalization at the age of three for thirteen days at a pediatric referral center due to Guillain-Barré syndrome. During the current hospitalization, cerebrospinal fluid analysis demonstrated elevated protein levels, and nerve conduction studies revealed a demyelinating polyneuropathy consistent with Guillain-Barré syndrome. Treatment with intravenous immunoglobulin at a dose of 0.4 g/kg/day for five consecutive days was initiated, with follow-up by the pediatric neurology team, resulting in progressive recovery of muscle strength and improvement in ambulation with support. This case emphasizes the importance of considering Guillain-Barré syndrome recurrence in pediatric patients, despite its rarity and the limited number of cases reported in the literature.
References
Bradshaw, D. Y., & Jones, H. R. Jr. (1992). Guillain-Barré syndrome in children: Clinical course, electrodiagnosis, and prognosis. Muscle & Nerve, 15(4), 500–506. https://doi.org/10.1002/mus.880150415
Bonilla, C., et al. (2022). Severe bradycardia in a teenager as the initial manifestation of Guillain-Barré syndrome. BMJ Case Reports, 15, e247826. https://doi.org/10.1136/bcr-2021-247826
Brasil. Ministério da Saúde. (2009). Protocolo Clínico e Diretrizes Terapêuticas: Síndrome de Guillain-Barré. Brasília: Ministério da Saúde.
Brasil. Ministério da Saúde. (2021). Protocolo Clínico e Diretrizes Terapêuticas da Síndrome de Guillain-Barré. Brasília: Ministério da Saúde.
Cruz, C. G., et al. (2015). Síndrome de Guillain-Barré com recidiva aguda em criança: Relato de caso. In 37º Congresso Brasileiro de Pediatria. Rio de Janeiro.
Dias-Tosta, E., & Kückelhaus, C. S. (2002). Guillain-Barré syndrome in a population less than 15 years old in Brazil. Arquivos de Neuro-Psiquiatria, 60(2-B), 367–373. https://doi.org/10.1590/S0004-282X2002000300005
Dukkipati, S. S., et al. (2022). Acute bulbar palsy plus variant of Guillain-Barré syndrome in a 3-year-old girl. Child Neurology Open, 9, 1–5. https://doi.org/10.1177/2329048X221115476
Fokke, C., et al. (2014). Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain, 137(1), 33–43. https://doi.org/10.1093/brain/awt285
Gonçalves, M. R., et al. (2017). Síndrome de Guillain-Barré en la infancia: Una revisión de la literatura. Ribeirão Preto: UNAERP.
Gordon, P. H. (2001). Early electrodiagnostic findings in Guillain-Barré syndrome. Muscle & Nerve, 24(9), 1141–1145.
Hadden, R. D. M., & Hughes, R. A. C. (2003). Management of inflammatory neuropathies. Journal of Neurology, Neurosurgery and Psychiatry, 74(Suppl. 2), ii9–ii14. https://doi.org/10.1136/jnnp.74.suppl_2.ii9
Hahn, A. F. (1998). Guillain-Barré syndrome. The Lancet, 352(9128), 635–641.
Heemstra, H. E., et al. (2008). Predictors of orphan drug approval in the European Union. European Journal of Clinical Pharmacology, 64(5), 463–471. https://doi.org/10.1007/s00228-007-0454-6
Hughes, R. A. C., et al. (2000). Pathogenesis of Guillain-Barré syndrome. Journal of Neuroimmunology, 100(1-2), 74–97. https://doi.org/10.1046/j.1529-8027.2000.absjun-23.x
Hughes, R. A. C., Swan, A. V., & Van Doorn, P. A. (2014). Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews, (9), CD002063. https://doi.org/10.1002/14651858.CD002063.pub6
João, P. R. D. (2014). Síndrome de Guillain-Barré. PROTIPED, 1, 9–56.
Karalok, Z. S., et al. (2018). Guillain-Barré syndrome in children: Subtypes and outcome. Child’s Nervous System, 34(11), 2291–2297. https://doi.org/10.1007/s00381-018-3856-0
Khan, F., et al. (2010). Multidisciplinary care for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews, (10), CD008505. https://doi.org/10.1002/14651858.CD008505.pub2
Kieseier, B. C., & Hartung, H. P. (2003). Therapeutic strategies in the Guillain-Barré syndrome. Seminars in Neurology, 23(2), 159–168. https://doi.org/10.1055/s-2003-41132
Korinthënberg, R., et al. (2020). Diagnosis and treatment of Guillain-Barré syndrome in childhood and adolescence. European Journal of Paediatric Neurology, 25, 5–16. https://doi.org/10.1016/j.ejpn.2020.01.003
Lucca, M. E. T., et al. (2022). Síndrome de Guillain-Barré na pediatria: Revisão de literatura. Residência Pediátrica, 12(3).
Mello, A. R., Freitas, M. R. G., & Chimelli, L. (1989). Chronic recurrent Guillain-Barré syndrome: Report of three cases. Arquivos de Neuro-Psiquiatria, 47(1), 70–74.
Neves, M. A. O., et al. (2007). Síndrome de Guillain-Barré na infância: Relato de caso. Revista Neurociências, 15(4), 329–333.
Pereira, S. L. (2024). Metodologia da pesquisa científica. https://doi.org/10.63715/9786581075057
Pinto Silva, M. J., et al. (2015). Síndrome de Guillain-Barré recorrente: Caso clínico. SPMFR, 27(2).
Romano, J. G., et al. (1998). Relapses in the Guillain-Barré syndrome after treatment with intravenous immune globulin or plasma exchange. Muscle & Nerve, 21(10), 1327–1332. https://doi.org/10.1002/(SICI)1097-4598(199810)21:10<1327::AID-MUS14>3.0.CO;2-9
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [free ebook]. Santa Maria: Editora da UFSM.
Ryan, M. M. (2013). Pediatric Guillain-Barré syndrome. Current Opinion in Pediatrics, 25(6), 689–693. https://doi.org/10.1097/MOP.0b013e328365ad3f
Shahrizaila, N., Lehmann, H. C., & Kuwabara, S. (2021). Guillain-Barré syndrome. The Lancet, 397(10280), 1214–1228. https://doi.org/10.1016/S0140-6736(21)00517-1
Sharma, G. S., et al. (2021). Rare clinical presentation in a case of pediatric Guillain-Barré syndrome. Journal of Neurosciences in Rural Practice, 12(2), 319–322. https://doi.org/10.1055/s-0041-1727299
Souza, M. M., et al. (2018). Síndrome de Guillain-Barré em criança: Relato de caso. Boletim Científico de Pediatria, 7(1), 4.
Van Doorn, P. A. (2013). Diagnosis, treatment and prognosis of Guillain-Barré syndrome. La Presse Médicale, 42(6 Pt 2), e193–e201. https://doi.org/10.1016/j.lpm.2013.02.328
Vega Castro, R., et al. (2021). Case report of Guillain-Barré syndrome in an eleven-month-old infant. Journal of Medical Cases, 12(3), 85–89. https://doi.org/10.14740/jmc3638
Vucic, S., Kiernan, M. C., & Cornblath, D. R. (2009). Guillain-Barré syndrome: An update. Journal of Clinical Neuroscience, 16(6), 733–741. https://doi.org/10.1016/j.jocn.2008.08.033
Walling, A. D., & Dickson, G. (2013). Guillain-Barré syndrome. American Family Physician, 87(3), 191–197.
Yin, R. K. (2015). Estudo de caso: Planejamento e métodos (5ª ed.). Porto Alegre: Bookman.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Guilherme Augusto Vassoler Panuci, Andrea Helena Érnica Bisol
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
